Stakeholders have called on the Federal Government to prioritise easing local pharmaceutical manufacturers’ challenges, including a harsh trade and regulatory environment, as it seeks to attract foreign investment into the sector. The former president of the Pharmaceutical Society of Nigeria, Olumide Akintayo, stressed that an enabling business environment is crucial for the industry to thrive. Akintayo says that local manufacturers must not be left to struggle under burdensome tariffs and high operational costs. He also questioned the effectiveness of President Bola Tinubu’s executive order, signed in June 2024, waiving duty payments on the importation of certain pharmaceutical inputs.
Become a supporter of this podcast: https://www.spreaker.com/podcast/africa-business-news--4166630/support.